ArticleThe Journal of biological chemistry2015

Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.

Yiming Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.